TVM Capital Life Science Announces €8 Million Investment in myo to Revolutionize Elderly Care via Innovative, Easy-to-Use App

Gedeon Richter becomes strategic investor of Formycon via equity investment

Affluent Medical closes €3.5 million bridge via capital increase from key shareholders

InflaRx Announces Initiation of its Commitment Program for GOHIBIC®(vilobelimab) to Help Broaden Access for Eligible Patients

G.ST Antivirals reports positive Phase I trial results for 2-Deoxy-D-glucose against upper respiratory infections

AiCuris and the German Center for Infection Research (DZIF) sign Collaboration and License Option Agreement

Abivax to host KOL Investor Event to review phase 2b clinical data and phase 3 trial design for obefazimod in patients with moderately to severely active ulcerative colitis on February 6, 2024

BioLizard announces Swiss subsidiary and service offering for AI-powered digital transformation of life sciences at Biopôle in Lausanne

Abivax provides 2024 strategic outlook and lays out key milestones over next 12 months

Kizoo leads financing round in Reservoir Neuroscience to restore health to the aging brain